InvestSMART

Control Bionics Limited (ASX: CBL) - Announcements

Current share price for CBL : $0.052 0.003 (6.12%)+

ASX company news and announcements for Control Bionics Limited (CBL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Control Bionics Limited (CBL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Control Bionics Limited (CBL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Control Bionics Limited (CBL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$28 NeuroStrip secures MHRA registration 25 Aug 2026 9:49AM $0.058 $0.052 fallen by 10.34%
$28 Notification regarding unquoted securities - CBL 12 Aug 2026 10:52AM $0.062 $0.052 fallen by 16.13%
$28 Change in substantial holding - Nightingale 12 Aug 2026 10:49AM $0.064 $0.052 fallen by 18.75%
$28 Change in substantial holding - Phoenix 12 Aug 2026 10:33AM $0.064 $0.052 fallen by 18.75%
$28 Change of Director's Interest Notice - Steele 12 Aug 2026 10:01AM $0.064 $0.052 fallen by 18.75%
$28 Change of Director's Interest Notice - Opie 12 Aug 2026 10:00AM $0.062 $0.052 fallen by 16.13%
$28 Change of Director's Interest Notice - Heard 12 Aug 2026 9:56AM $0.062 $0.052 fallen by 16.13%
$28 Change of Director's Interest Notice - Lismore 12 Aug 2026 9:55AM $0.062 $0.052 fallen by 16.13%
$28 Change of Director's Interest Notice - Rix 12 Aug 2026 9:50AM $0.062 $0.052 fallen by 16.13%
$28 Cleansing notice 12 Aug 2026 9:50AM $0.062 $0.052 fallen by 16.13%
$28 Application for quotation of securities - CBL 12 Aug 2026 9:45AM $0.062 $0.052 fallen by 16.13%
$28 NeuroStrip App Launch on Apple and Microsoft Stores 12 Aug 2026 8:49AM $0.062 $0.052 fallen by 16.13%
$28 Notification regarding unquoted securities - CBL 11 Aug 2026 1:11PM $0.064 $0.052 fallen by 18.75%
$28 Results of Meeting 6 Aug 2026 12:04PM $0.069 $0.052 fallen by 24.64%
$28 US FDA Registration and Device Listing for NeuroStrip 4 Aug 2026 8:26AM $0.065 $0.052 fallen by 20%
$28 Commercial momentum builds across both platform pillars 31 Jul 2026 9:10AM $0.066 $0.052 fallen by 21.21%
$28 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2026 8:31AM $0.066 $0.052 fallen by 21.21%
$28 Change of Director's Interest Notice - Rix 21 Jul 2026 11:54AM $0.067 $0.052 fallen by 22.39%
$28 Application for quotation of securities - CBL 21 Jul 2026 9:46AM $0.068 $0.052 fallen by 23.53%
$28 SPP results 21 Jul 2026 9:45AM $0.068 $0.052 fallen by 23.53%
$28 Notification of cessation of securities - CBL 7 Jul 2026 12:28PM $0.073 $0.052 fallen by 28.77%
$28 Notification regarding unquoted securities - CBL 6 Jul 2026 5:13PM $0.075 $0.052 fallen by 30.67%
$28 Notice of General Meeting/Proxy Form 6 Jul 2026 1:25PM $0.073 $0.052 fallen by 28.77%
$28 Change in substantial holding - Phoenix 3 Jul 2026 3:59PM $0.074 $0.052 fallen by 29.73%
$28 SPP Cleansing Notice 2 Jul 2026 10:50AM $0.072 $0.052 fallen by 27.78%

26 - 50 of 642 results

Page 2 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.